We are live on
!
Find out more
AWM
Aevitas Wealth Management Portfolio holdings
AUM
$169M
1-Year Est. Return
9.55%
This Fund
S&P 500
This Quarter
Est. Return
+1.54%
1 Year Est. Return
-9.55%
3 Year Est. Return
+36.41%
5 Year Est. Return
+72.53%
10 Year Est. Return
–
AUM
$143M
AUM Growth
+$6.76M
(+5%)
Cap. Flow
+$6.04M
Cap. Flow
% of AUM
4.21%
Top 10 Holdings %
Top 10 Hldgs %
38.8%
Holding
124
New
10
Increased
75
Reduced
23
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARK Genomic Revolution ETF
ARKG
|
+$1.55M |
| 2 |
ARK Innovation ETF
ARKK
|
+$1.42M |
| 3 |
ARK Blockchain & Fintech Innovation ETF
ARKF
|
+$1.12M |
| 4 |
Novartis
NVS
|
+$824K |
| 5 |
State Street SPDR Bloomberg Convertible Securities ETF
CWB
|
+$484K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enbridge
ENB
|
+$971K |
| 2 |
Pfizer
PFE
|
+$463K |
| 3 |
Otis Worldwide
OTIS
|
+$269K |
| 4 |
MongoDB
MDB
|
+$269K |
| 5 |
Compass Minerals
CMP
|
+$232K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.16% |
| 2 | Healthcare | 13.99% |
| 3 | Consumer Staples | 10.68% |
| 4 | Consumer Discretionary | 7.68% |
| 5 | Communication Services | 6.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.72T
| $8.8M | 6.14% |
72,066
+2,341
| +3% | +$300K |
|
2
SPDR Gold Trust
GLD
$130B
| $8.61M | 6.01% |
53,838
-95
| -0.2% | -$16K |
|
3
Microsoft
MSFT
$2.83T
| $8.3M | 5.79% |
35,207
+579
| +2% | +$134K |
|
4
Amazon
AMZN
$2.51T
| $6.35M | 4.43% |
41,020
+2,560
| +7% | +$406K |
|
5
Johnson & Johnson
JNJ
$624B
| $5.06M | 3.53% |
30,799
+954
| +3% | +$154K |
|
6
PepsiCo
PEP
$184B
| $4.56M | 3.18% |
32,226
+201
| +0.6% | +$27.6K |
|
7
Vanguard Health Care ETF
VHT
$18.1B
| $4.52M | 3.15% |
19,763
+7
| +0% | +$1.6K |
|
8
Becton Dickinson
BDX
$42.1B
| $3.51M | 2.45% |
14,800
+355
| +2% | +$86.7K |
|
9
Comcast
CMCSA
$78.3B
| $2.99M | 2.08% |
55,238
+481
| +0.9% | +$25.4K |
|
10
Alphabet (Google) Class C
GOOG
$3.88T
| $2.92M | 2.04% |
28,260
+140
| +0.5% | +$13.9K |
|
|
11
ARK Innovation ETF
ARKK
$6.05B
| $2.89M | 2.02% |
24,106
+10,479
| +77% | +$1.42M |
|
12
Palo Alto Networks
PANW
$265B
| $2.69M | 1.88% |
50,088
+498
| +1% | +$29.6K |
|
13
Accenture
ACN
$84.9B
| $2.32M | 1.62% |
8,383
+70
| +0.8% | +$18.1K |
|
14
Vanguard Dividend Appreciation ETF
VIG
$110B
| $2.3M | 1.61% |
15,668
+19
| +0.1% | +$2.7K |
|
15
Stryker
SYK
$122B
| $2.22M | 1.55% |
9,129
+11
| +0.1% | +$2.64K |
|
16
Vanguard Financials ETF
VFH
$13.2B
| $2.04M | 1.42% |
24,095
+843
| +4% | +$67.2K |
|
17
Procter & Gamble
PG
$342B
| $1.99M | 1.38% |
14,654
-3
| -0% | -$391 |
|
18
Vanguard Information Technology ETF
VGT
$140B
| $1.84M | 1.28% |
41,040
-328
| -0.8% | -$14.8K |
|
19
Vanguard Total International Stock ETF
VXUS
$153B
| $1.83M | 1.28% |
29,238
-1,922
| -6% | -$121K |
|
20
American Tower
AMT
$76.7B
| $1.83M | 1.28% |
7,656
+9
| +0.1% | +$2K |
|
21
Clorox
CLX
$11.3B
| $1.77M | 1.24% |
9,183
+12
| +0.1% | +$2.31K |
|
22
AbbVie
ABBV
$454B
| $1.71M | 1.19% |
15,803
+198
| +1% | +$21.2K |
|
23
CrowdStrike
CRWD
$187B
| $1.7M | 1.18% |
37,152
+1,200
| +3% | +$63.5K |
|
24
McDonald's
MCD
$187B
| $1.69M | 1.18% |
7,558
+137
| +2% | +$29.3K |
|
25
Coca-Cola
KO
$349B
| $1.61M | 1.12% |
30,500
-1,442
| -5% | -$72.6K |
|
Similar funds
CCM
BA
BFS
RCC
S
RCA
SCM
WWA
Aevitas Wealth Management's Q1 2021 Portfolio in Review
As of Q1 2021, Aevitas Wealth Management held 124 positions worth $143M, up 5% from $137M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Aevitas Wealth Management deployed $6.04M of net new capital in Q1 2021, opening 10 new positions and adding to 75 existing holdings. Its largest new stake was ARK Genomic Revolution ETF: 15,649 shares worth $1.39M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Staples.
On the sell side, the largest reduction was Vanguard Total International Stock ETF, an estimated $121K trimmed.
- Aevitas Wealth Management's largest Q1 2021 buy was ARK Genomic Revolution ETF: 15,649 shares worth $1.39M.
- Aevitas Wealth Management added most to ARK Innovation ETF in Q1 2021, an estimated $1.42M increase.
- Aevitas Wealth Management's biggest Q1 2021 reduction was Vanguard Total International Stock ETF, cutting an estimated $121K.
- Aevitas Wealth Management fully exited Enbridge in Q1 2021, selling an estimated $971K.
- Aevitas Wealth Management's ten largest holdings make up 39% of its $143M portfolio in Q1 2021.
- Aevitas Wealth Management opened 10 new positions and closed 6 in Q1 2021.
- Aevitas Wealth Management's portfolio value rose 5% quarter-over-quarter to $143M.
Based on Aevitas Wealth Management's 13F filing for Q1 2021, filed 29 Apr 2021.